Phospho-Smad3 (Ser423/Ser425) Antibody

Skip to product information
1 of 2

Selleck Chemicals

SKU:F2846-20UL

Regular price €159,00 EUR
Regular price Sale price €159,00 EUR
Sale Sold out
Shipping calculated at checkout.
Size
Quantity
View full details

About the Target

Phospho-Smad3 (Ser 423/Ser 425) refers to the phosphorylated form of Smad3 at two critical serine residues located at its C-terminus, essential for TGF-β signaling. Upon activation by TGF-β, the Type I receptor kinase (TβRI) phosphorylates Smad3 at Ser 423 and Ser 425, inducing a conformational change that facilitates its dissociation from the receptor complex. Depending on the literature source, SMAD3 may also be discussed as Phospho-Smad3 (Ser423/Ser425) and Phospho-Smad3 (Ser 423/425)+Smad5 (Ser 463/465)+Smad1 (Ser 463/465)+Smad2 (Ser 465/467).

Reported cellular context includes cytoplasm and nucleus, which can matter when signal is compared across treatments or changing cell states. Following SMAD3 across matched perturbations can help separate abundance effects from shifts in localization, complex assembly, or pathway state.

Research Context

SMAD3 is commonly interpreted in the context of cell signaling research, and readouts are often stronger when a study separates expression changes from compartment-level redistribution. When reported signal spans cytoplasm and nucleus, a defined reference condition can make comparisons more interpretable across perturbations, passages, or replicate sets.

Consider these angles when interpreting target-level changes:

  • apparent redistribution between cytoplasm and nucleus across matched conditions
  • signal-dependent shifts after ligand, inhibitor, or growth-factor perturbation
  • differences between total target abundance and site-specific regulation when modified forms are compared
  • co-patterning with orthogonal markers and control conditions that clarify pathway state

Variant Considerations

If your project spans exploratory questions, the regular version offers a balanced option for establishing baseline signal behavior for SMAD3. This can help when protocols evolve over time and the goal is to compare experiments using a stable reference workflow.

Standardize sampling time, control choice, and downstream analysis thresholds so apparent differences in SMAD3 reflect biology rather than handling. When interpreting SMAD3, it is often useful to decide early whether the main question is overall abundance, compartmental enrichment, or context-dependent redistribution.

For multi-run studies, a shared reference condition can keep SMAD3 trends easier to compare across datasets. That kind of consistency is especially helpful when follow-up work expands to new perturbations, model systems, or longitudinal collections.

Targets:
SMAD3
Research Area:
Cell Signaling
Application:
IF • IHC • WB
Reactivity:
Human • Mouse
Specificity:
Phospho-Smad3 (Ser423/Ser425) Antibody [L3N2] detects endogenous levels of Smad3 only when phosphorylated at Ser 423/Ser 425.<span style="color: rgb(30, 30, 30); font-family: " century="" gothic",="" arial,="" stxihei,="" 华文细黑,="" "microsoft="" yahei="" new",="" yahei",="" 微软雅黑,="" 宋体,="" simsun,="" serif;="" font-size:="" 14px;"="">This Smad3 antibody may also detect Smad1, Smad2 and Smad5 phosphorylated at the equivalent sites.
Host:
Rabbit
Clonality:
Monoclonal
Clone:
L3N2
UniProt:
P84022
Storage Buffer:
PBS, pH 7.2+50% Glycerol+0.05% BSA+0.01% NaN₃
Storage Temperature:
-20°C

For Research Use Only. Not intended for diagnostic or therapeutic use.
Products may be subject to intellectual property rights.

The purchase of this product does not grant any license for commercial use, manufacturing, or clinical applications. The user is responsible for ensuring compliance with applicable laws and third-party rights.